While most of the world’s research community seeks to develop sophisticated drugs that could prevent or correct the problems associated … Read More
Modulation of Rit2 expression to protect against alpha-synuclein neuropathology
A protein called alpha-synuclein, which accumulates in clumps in the brain cells of people with Parkinson’s disease, has long been … Read More
Protecting crucial brain cells from too much calcium
Within the last decade, researchers discovered that people taking drugs that block calcium channels to treat high blood pressure enjoy … Read More
Helping people with Parkinson’s drive longer and safer
Driving is key to keeping people independent and healthy. For people with Parkinson’s, including many who are diagnosed with the … Read More
Recruiting the brain’s underdogs
About half of the human brain is made up of cells, known as astrocytes, which researchers used to think were … Read More
Preventing a cure from becoming as bad as the disease
The drug levodopa, or L-Dopa, remains the most effective and widely prescribed treatment for the symptoms of Parkinson’s disease, but … Read More
Connecting transplanted brain cells
Neuroscientist Caroline Lafrechoux has been fascinated with the networks of neurons and electrical signals in the brain since she was … Read More
Easing the pain of Parkinson’s
Pain is a constant companion for as many as 10 percent of people with Parkinson’s disease. Unfortunately, most of them … Read More
Speaking up for Parkinson’s patients
Speaking at a near whisper is a hallmark of Parkinson’s disease, but the cause and effective treatment of this problem … Read More
Reigning in impulsivity
Up to 20 percent of people with Parkinson’s disease who take a new class of drugs to help reduce their … Read More